Condition: Cardiomyopathy, Dilated · Sponsor: University Medical Centre Ljubljana
Although several studies have demonstrated beneficial effects of stem cell therapy in patients with non-ischemic dilated cardiomyopathy, the long term benefits and predictors of response to therapy remain undefined. The aim of this registry is to pool long-term clinical data in patients with non-ischemic dilated cardiomyopathy undergoing autologous cell therapy in an attempt to better define predictors of response to such treatment.
This description comes directly from the study's public registry record.
Bojan Vrtovec, MD, PhD · +3861 522 1157 · bojan.vrtovec@gmail.com
Gregor Poglajen, MD, PhD · +3861 522 1148 · gregor.poglajen@gmail.com
Always discuss trial participation with your own doctor first.
| UMC Ljubljana | Ljubljana, Slovenia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02445534